ASSESSING THE QUALITY OF LIFE IN PARKINSON'S DISEASE
Author(s)
Spottke AE1, Reuter M1, Smala A2, Berger K2, Athen O3, Köhne-Volland R3, Meyer D3, Oertel WH1, Dodel RC1 , 1Philipps-University Marburg, Marburg, Germany; 2MERG - Medical Economics Research Group, Munich, Germany; 3Metronomia, Munich, Germany
OBJECTIVES: To assess the influence of depression, dementia and disease severity on the health-related quality of life in Parkinson's disease (PD). METHODS: Health-related quality of life was assessed in 91 patients with PD (male: 62; female: 29; mean age: 67±9) using the Parkinson's disease questionnaire (PDQ-39) and the Parkinson's disease Quality of life questionnaire (PDQL). Dementia was evaluated by using the MMSE and depression was rated with the Beck's Depression Inventory (BDI). Disease severity and motor dysfunction were recorded with the Hoehn and Yahr scale and the UPDRS II-IV. Pearson's correlation coefficient was used to calculate correlation scores.. RESULTS: Both specific disease QoL rating scales correlated with depressive symptoms (r = 0.73, p < .0001). UPDRS III (r = 0.69, p < .0001) and HY stage (r = .59, p < .001) also correlated with decreased QoL. However, motor fluctuations and dyskinesias had a minor impact on QoL (r = 0.40, p < .001). Dementia or cognitive impairment had a minor correlation with QoL (r = 0.30, p = .001). CONCLUSIONS: We found a high correlation between QoL and depression by using PDQ-39 and PDQL. In contrast, a minor correlation was observed between MMSE scores and health-related QoL. Treating depressive symptoms in PD patients may considerably improve the quality of life of patients with Parkinson's disease.
Conference/Value in Health Info
2001-11, ISPOR Europe 2001, Cannes, France
Value in Health, Vol. 4, No. 6 (November/December 2001)
Code
ND2
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Neurological Disorders